Related Experiment Video

Updated: Feb 15, 2026

Author Spotlight: Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue
07:31

Author Spotlight: Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue

Published on: May 26, 2023

6.1K

MiR-137 functions as a tumor suppressor in pancreatic cancer by targeting MRGBP

Feng Ding1,2, Shuang Zhang3, Shaoyang Gao4

  • 1Department of Gastroenterology/Hepatology, ZhongNan Hospital of Wuhan University, Wuhan, China.

Journal of Cellular Biochemistry
|January 14, 2018
PubMed

Insights

MicroRNA-137 (miR-137) is downregulated in pancreatic cancer and suppresses tumor growth by targeting MRGBP. Restoring miR-137 levels may offer a new therapeutic strategy for pancreatic cancer.

Area of Science:

  • Molecular Biology
  • Oncology
  • Epigenetics

Background:

  • MicroRNAs (miRNAs) are key epigenetic regulators in cancer development.
  • Pancreatic cancer (PanCa) is characterized by complex genetic and epigenetic alterations.
  • Dysregulation of specific miRNAs can significantly impact tumor progression.

Purpose of the Study:

  • To investigate the role of miR-137 in pancreatic cancer.
  • To identify the downstream targets of miR-137 in PanCa.
  • To explore the potential of miR-137 as a therapeutic agent.

Main Methods:

  • Analysis of miR-137 expression in human PanCa tissues and cell lines.
  • Functional assays to assess the effects of miR-137 on cell proliferation, apoptosis, migration, and invasion.
  • Identification and validation of miR-137 direct targets using molecular techniques.
  • Comparison of miR-137 effects with the effects of its target gene silencing.

Main Results:

  • miR-137 was significantly downregulated in PanCa tissues and cell lines.
  • Low miR-137 levels correlated with increased tumor size, advanced TNM stage, and poor prognosis.
  • Overexpression of miR-137 suppressed PanCa cell proliferation, induced apoptosis, and inhibited migration/invasion.
  • MRGBP was identified as a direct target of miR-137, with its expression reduced upon miR-137 upregulation.
  • Silencing MRGBP mimicked the tumor-suppressive effects of miR-137 overexpression.

Conclusions:

  • miR-137 acts as a tumor suppressor in pancreatic cancer.
  • The miR-137/MRGBP axis plays a critical role in PanCa progression.
  • miR-137 represents a potential therapeutic target for pancreatic cancer treatment.
Keywords:
MRGBPapoptosismiR-137pancreatic cancer (PanCa)proliferation

More Related Videos

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

1.9K
Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models09:18

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models

Published on: February 3, 2026

374

Related Concept Videos

Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.1K
Pancreatic Juice and Secretion01:26

Pancreatic Juice and Secretion

Pancreatic juice is a clear fluid produced by the pancreas, containing water, salts, sodium bicarbonate, and enzymes vital for digestion in the small intestine. It helps break down large molecules, facilitating nutrient absorption.
When acidic chyme from the stomach enters the duodenum, it triggers the release of secretin, a hormone that prompts pancreatic juice secretion. After a fatty meal, cholecystokinin, another hormone, stimulates gallbladder contraction and enhances enzyme-rich...
3.1K
Acute Pancreatitis I: Introduction01:27

Acute Pancreatitis I: Introduction

Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
1.3K